Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lamarche

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Molecular Cancer Therapeutics|August 24, 2019
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant CancersHuai-Xiang Hao, Hongyun Wang, Chen Liu, et al.
Journal of Medicinal Chemistry|January 10, 2024
Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal MelanomaMichael Visser, Julien P N Papillon, Michael Luzzio, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
In vitro and in vivo activities of novel, semisynthetic thiopeptide inhibitors of bacterial elongation factor TuJ A Leeds, M J LaMarche, J T Brewer, et al.
Journal of Medicinal Chemistry|January 29, 2019
Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonistsAnil Vasudevan, Matthew J LaMarche, Christopher Blackburn, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
ACS Chemical Biology|January 6, 2018
Dual Allosteric Inhibition of SHP2 PhosphataseMichelle Fodor, Edmund Price, Ping Wang, et al.
Journal of Medicinal Chemistry|January 29, 2019
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Journal of Medicinal Chemistry|February 10, 2012
Discovery of LFF571: an investigational agent for Clostridium difficile infectionMatthew J LaMarche, Jennifer A Leeds, Adam Amaral, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to 6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Molecular Cancer Therapeutics|August 24, 2019
Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant CancersHuai-Xiang Hao, Hongyun Wang, Chen Liu, et al.
Journal of Medicinal Chemistry|January 10, 2024
Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal MelanomaMichael Visser, Julien P N Papillon, Michael Luzzio, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
In vitro and in vivo activities of novel, semisynthetic thiopeptide inhibitors of bacterial elongation factor TuJ A Leeds, M J LaMarche, J T Brewer, et al.
Journal of Medicinal Chemistry|January 29, 2019
Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonistsAnil Vasudevan, Matthew J LaMarche, Christopher Blackburn, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to Optimization of Fused Bicyclic Allosteric SHP2 InhibitorsJeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, et al.
ACS Chemical Biology|January 6, 2018
Dual Allosteric Inhibition of SHP2 PhosphataseMichelle Fodor, Edmund Price, Ping Wang, et al.
Journal of Medicinal Chemistry|January 29, 2019
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Journal of Medicinal Chemistry|February 10, 2012
Discovery of LFF571: an investigational agent for Clostridium difficile infectionMatthew J LaMarche, Jennifer A Leeds, Adam Amaral, et al.
Journal of Medicinal Chemistry|March 23, 2019
Correction to 6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 InhibitorsPatrick Sarver, Michael Acker, Jeffrey T Bagdanoff, et al.
Pageof 10